Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats

Joy L. Stone, Joel B. Braunstein, Timothy M. Beaty, Ruth A. Sanders, John B. Watkins

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Divergent opinions regarding the effect of streptozotocin- (STZ) induced diabetes on bile flow rate may be due to the differing lengths of time after STZ administration at which bile flow was measured. Also, the biliary excretion of bile acids can influence the canalicular transport of several organic anions. Therefore, the hepatic clearance of the bile acid-dependent organic anion rose bengal was studied over a 30-day period in STZ-induced insulin-dependent Sprague-Dawley diabetic rats with elevated bile acid pools and in fatty noninsulin-dependent diabetic and lean Wistar rats. Excretion of total bile acids and rose bengal was higher in diabetic rats than in Sprague- Dawley control or lean or fatty Wistar rats. Depletion of bile acids for 10 hr in the 30-day STZ rat prevented the increased excretion of rose bengal. Bile flow rates in fatty and lean Wistar rats were similar to that in Sprague-Dawley controls. Increased bile acid excretion 7 and 14 days after STZ was not accompanied by the expected significant increase in bile flow, reflecting decreased bile acid-independent bile flow, regardless of method of calculation of bile flow (per g liver or per kg body weight). By 30 days, there were significant increases in bile acid excretion and bile flow. The increased clearance of rose bengal 7 days after STZ indicates that pathophysiological changes in the hepatocyte begin soon after the initiation of diabetes. Studies of taurocholate uptake into liver plasma membrane vesicles indicated that the maximal velocity of transport across the basolateral membrane was increased with no change in K(m). This change was not observed in vesicles from insulin-treated diabetic rats. Therefore, studies employing STZ need to allow time for STZ toxicity to be overcome and for the pathology of diabetes to become established, to accurately reflect the diabetic condition.

Original languageEnglish
Pages (from-to)412-419
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume281
Issue number1
StatePublished - 1997

Fingerprint

Rose Bengal
Streptozocin
Bile Acids and Salts
Bile
Wistar Rats
Anions
Sprague Dawley Rats
Liver
Insulin
Taurocholic Acid
Experimental Diabetes Mellitus
Hepatobiliary Elimination
Hepatocytes
Body Weight
Cell Membrane
Pathology
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Stone, J. L., Braunstein, J. B., Beaty, T. M., Sanders, R. A., & Watkins, J. B. (1997). Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats. Journal of Pharmacology and Experimental Therapeutics, 281(1), 412-419.

Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats. / Stone, Joy L.; Braunstein, Joel B.; Beaty, Timothy M.; Sanders, Ruth A.; Watkins, John B.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 281, No. 1, 1997, p. 412-419.

Research output: Contribution to journalArticle

Stone, Joy L. ; Braunstein, Joel B. ; Beaty, Timothy M. ; Sanders, Ruth A. ; Watkins, John B. / Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats. In: Journal of Pharmacology and Experimental Therapeutics. 1997 ; Vol. 281, No. 1. pp. 412-419.
@article{1eeedf26bee44997bb7f85279d79efcb,
title = "Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats",
abstract = "Divergent opinions regarding the effect of streptozotocin- (STZ) induced diabetes on bile flow rate may be due to the differing lengths of time after STZ administration at which bile flow was measured. Also, the biliary excretion of bile acids can influence the canalicular transport of several organic anions. Therefore, the hepatic clearance of the bile acid-dependent organic anion rose bengal was studied over a 30-day period in STZ-induced insulin-dependent Sprague-Dawley diabetic rats with elevated bile acid pools and in fatty noninsulin-dependent diabetic and lean Wistar rats. Excretion of total bile acids and rose bengal was higher in diabetic rats than in Sprague- Dawley control or lean or fatty Wistar rats. Depletion of bile acids for 10 hr in the 30-day STZ rat prevented the increased excretion of rose bengal. Bile flow rates in fatty and lean Wistar rats were similar to that in Sprague-Dawley controls. Increased bile acid excretion 7 and 14 days after STZ was not accompanied by the expected significant increase in bile flow, reflecting decreased bile acid-independent bile flow, regardless of method of calculation of bile flow (per g liver or per kg body weight). By 30 days, there were significant increases in bile acid excretion and bile flow. The increased clearance of rose bengal 7 days after STZ indicates that pathophysiological changes in the hepatocyte begin soon after the initiation of diabetes. Studies of taurocholate uptake into liver plasma membrane vesicles indicated that the maximal velocity of transport across the basolateral membrane was increased with no change in K(m). This change was not observed in vesicles from insulin-treated diabetic rats. Therefore, studies employing STZ need to allow time for STZ toxicity to be overcome and for the pathology of diabetes to become established, to accurately reflect the diabetic condition.",
author = "Stone, {Joy L.} and Braunstein, {Joel B.} and Beaty, {Timothy M.} and Sanders, {Ruth A.} and Watkins, {John B.}",
year = "1997",
language = "English",
volume = "281",
pages = "412--419",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Hepatobiliary excretion of bile acids and rose bengal in streptozotocin- induced and genetic diabetic rats

AU - Stone, Joy L.

AU - Braunstein, Joel B.

AU - Beaty, Timothy M.

AU - Sanders, Ruth A.

AU - Watkins, John B.

PY - 1997

Y1 - 1997

N2 - Divergent opinions regarding the effect of streptozotocin- (STZ) induced diabetes on bile flow rate may be due to the differing lengths of time after STZ administration at which bile flow was measured. Also, the biliary excretion of bile acids can influence the canalicular transport of several organic anions. Therefore, the hepatic clearance of the bile acid-dependent organic anion rose bengal was studied over a 30-day period in STZ-induced insulin-dependent Sprague-Dawley diabetic rats with elevated bile acid pools and in fatty noninsulin-dependent diabetic and lean Wistar rats. Excretion of total bile acids and rose bengal was higher in diabetic rats than in Sprague- Dawley control or lean or fatty Wistar rats. Depletion of bile acids for 10 hr in the 30-day STZ rat prevented the increased excretion of rose bengal. Bile flow rates in fatty and lean Wistar rats were similar to that in Sprague-Dawley controls. Increased bile acid excretion 7 and 14 days after STZ was not accompanied by the expected significant increase in bile flow, reflecting decreased bile acid-independent bile flow, regardless of method of calculation of bile flow (per g liver or per kg body weight). By 30 days, there were significant increases in bile acid excretion and bile flow. The increased clearance of rose bengal 7 days after STZ indicates that pathophysiological changes in the hepatocyte begin soon after the initiation of diabetes. Studies of taurocholate uptake into liver plasma membrane vesicles indicated that the maximal velocity of transport across the basolateral membrane was increased with no change in K(m). This change was not observed in vesicles from insulin-treated diabetic rats. Therefore, studies employing STZ need to allow time for STZ toxicity to be overcome and for the pathology of diabetes to become established, to accurately reflect the diabetic condition.

AB - Divergent opinions regarding the effect of streptozotocin- (STZ) induced diabetes on bile flow rate may be due to the differing lengths of time after STZ administration at which bile flow was measured. Also, the biliary excretion of bile acids can influence the canalicular transport of several organic anions. Therefore, the hepatic clearance of the bile acid-dependent organic anion rose bengal was studied over a 30-day period in STZ-induced insulin-dependent Sprague-Dawley diabetic rats with elevated bile acid pools and in fatty noninsulin-dependent diabetic and lean Wistar rats. Excretion of total bile acids and rose bengal was higher in diabetic rats than in Sprague- Dawley control or lean or fatty Wistar rats. Depletion of bile acids for 10 hr in the 30-day STZ rat prevented the increased excretion of rose bengal. Bile flow rates in fatty and lean Wistar rats were similar to that in Sprague-Dawley controls. Increased bile acid excretion 7 and 14 days after STZ was not accompanied by the expected significant increase in bile flow, reflecting decreased bile acid-independent bile flow, regardless of method of calculation of bile flow (per g liver or per kg body weight). By 30 days, there were significant increases in bile acid excretion and bile flow. The increased clearance of rose bengal 7 days after STZ indicates that pathophysiological changes in the hepatocyte begin soon after the initiation of diabetes. Studies of taurocholate uptake into liver plasma membrane vesicles indicated that the maximal velocity of transport across the basolateral membrane was increased with no change in K(m). This change was not observed in vesicles from insulin-treated diabetic rats. Therefore, studies employing STZ need to allow time for STZ toxicity to be overcome and for the pathology of diabetes to become established, to accurately reflect the diabetic condition.

UR - http://www.scopus.com/inward/record.url?scp=0031010251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031010251&partnerID=8YFLogxK

M3 - Article

C2 - 9103524

AN - SCOPUS:0031010251

VL - 281

SP - 412

EP - 419

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -